Northside Hospital Research Program

Find Open Clinical Trials

Return to Search

Managed Access Program (MAP) to provide access to CTL019, for acute lymphoblastic leukemia (ALL) or large B-cell lymphoma patients with out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial release.

Learn more:
http://www.clinicaltrials.gov/ct2/show/NCT03601442
Protocol Number
NSH1231
Phase
Other
Management Group
BMT Program
Oncology Group
BMT Oncology Group
Disease Sites
Lymphoid Leukemia
Sponsor Protocol
CCTL019B2003I
Principal Investigator
Scott Solomon
Scope
National
Participating Institutions
Northside Hospital - Atlanta (BMT)
Return to Search

Want to learn more?

For further information on our clinical trials, please call the Northside Hospital Research Program at (404) 303-3355 or

Email Us

For further information on our clinical trials, please contact the Northside Hospital Research Program at
(404) 303-3355 or

Call Us
Email Us